Search results for " hepatocellular"

showing 10 items of 592 documents

Hepatocellular carcinoma in patients with autoimmune hepatitis.

2009

To evaluate and confirm the low incidence of hepatocellular carcinoma (HCC) in patients with autoimmune hepatitis (AIH). At present only very few cases of HCC in patients with AIH and definite exclusion of chronic viral hepatitis have been published, suggesting that HCC due to AIH is rare.In order to further investigate the incidence of HCC in patients with AIH, we reviewed our large cohort of 278 patients with AIH.Eighty-nine patients (32%) were diagnosed with liver cirrhosis, a preneoplastic condition for HCC. We studied a total of 431 patient years of cirrhosis in these patients, an average 4.8 years per patient. During this period none of the patients of our own study cohort developed H…

Malemedicine.medical_specialtyCirrhosisAsiaCarcinoma HepatocellularAutoimmune hepatitisGastroenterologyCohort StudiesHepatitis B Chronicimmune system diseasesInternal medicineMedicineHumansneoplasmsAfrica South of the SaharaAgedHepatitisbusiness.industryLiver Cirrhosis BiliaryDeveloped CountriesIncidenceLiver NeoplasmsGastroenterologyGeneral MedicineHepatitis CHepatitis BHepatitis C ChronicMiddle Agedmedicine.diseasedigestive system diseasesBrief ArticlesHepatitis AutoimmuneHepatocellular carcinomaFemaleHemochromatosisbusinessLiver cancerViral hepatitisWorld journal of gastroenterology
researchProduct

Facing the dawn of immunotherapy for hepatocellular carcinoma.

2013

In this study, administration of tremelimumab was accompanied by a tolerable toxicity profile, most frequently including skin rash (65%), fatigue (55%), and anorexia (50%). During the initial course of tremilimumab, a transient increase of serum transaminase activity was observed. Hepatotoxicity did not impair liver function, even in the context of Child-Pugh B cirrhosis and hepatitis C. Therapy was stopped in 3 patients before tumor response evaluation was completed due to tremilimumab-related diarrhea or clinical deterioration, which was not associated with the treatment regimen. The relevance of this study is strengthened by the inclusion of HCC patients, showing hepatitis C associated c…

Malemedicine.medical_specialtyCirrhosisCarcinoma HepatocellularHepatitis C virusAntineoplastic Agentsmedicine.disease_causeAntibodies Monoclonal HumanizedGastroenterologyAntiviral AgentsInternal medicinemedicineHumansCTLA-4 AntigenHepatitisHepatologybusiness.industryLiver NeoplasmsAntibodies MonoclonalHepatitis CHepatitis C Chronicmedicine.diseaseRashHepatocellular carcinomaImmunologyFemaleLiver functionmedicine.symptombusinessTremelimumabmedicine.drugJournal of hepatology
researchProduct

Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre s…

2015

Background & Aims The role of hepatic resection for hepatocellular carcinoma (HCC) in different Barcelona Clinic Liver Cancer (BCLC) stages is controversial. We aimed at measuring the survival benefit of resection vs. non-surgical-therapies in each BCLC stage. Methods Using the ITA.LI.CA database, we identified 2090 BCLC A, B, and C HCC patients observed between 2000 and 2012: 550 underwent resection, 1046 loco-regional therapy (LRT), and 494 best supportive care (BSC). A multivariate log-logistic model was chosen to predict median survival (MS) after resection vs. MS after LRT or BSC. The results were expressed as net survival benefit of resection: (MS resection - MS LRT)/MS BSC. Resul…

Malemedicine.medical_specialtyCirrhosisCarcinoma HepatocellularLoco-regional therapieHepatocellular carcinomaSettore MED/12 - GASTROENTEROLOGIAHepatitis C virusKaplan-Meier Estimatemedicine.disease_causeGastroenterologyCohort StudiesLiver diseaseInterquartile rangeInternal medicinemedicineHumansBest supportive care; Cirrhosis; Hepatocellular carcinoma; Liver resection; Loco-regional therapies; Survival benefit; Aged; Carcinoma Hepatocellular; Cohort Studies; Female; Humans; Italy; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Treatment Outcome; Medicine (all); HepatologyBEST SUPPORTING CAREAgedNeoplasm StagingCirrhosiHepatologyPerformance statusLiver resectionbusiness.industryMedicine (all)CIRRHOISISCarcinomaLiver NeoplasmsHepatocellularMiddle Agedmedicine.diseasePrognosisBCLC StageTreatment OutcomeCirrhosisItalySurvival benefitHepatocellular carcinomaMultivariate AnalysisFemaleLoco-regional therapiesLiver cancerbusinessBest supportive careJournal of hepatology
researchProduct

Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological …

2013

Background: Radio-frequency ablation (RFA) has been employed in the treatment of Barcelona Clinic Liver Cancer (BCLC) early stage hepatocellular carcinoma (HCC) as curative treatments. Aim: To assess the effectiveness and the safety of RFA in patients with early HCC and compensated cirrhosis. Methods: A cohort of 151 consecutive patients with early stage HCC (122 Child-Pugh class A and 29 class B patients) treated with RFA were enrolled. Clinical, laboratory and radiological follow-up data were collected from the time of first RFA. A single lesion was observed in 113/151 (74.8%), two lesions in 32/151 (21.2%), and three lesions in 6/151 (4%) of patients. Results: The overall survival rates …

Malemedicine.medical_specialtyCirrhosisPercutaneousCarcinoma HepatocellularClinical Research Designmedicine.medical_treatmentCancer Treatmentlcsh:MedicineCatheter ablationGastroenterology and HepatologyGastroenterologyCohort StudiesInternal medicineGastrointestinal CancersGastrointestinal TumorsmedicineHumansStage (cooking)lcsh:ScienceAgedMultidisciplinaryRadiotherapybusiness.industryLiver Diseaseslcsh:RLiver NeoplasmsCancers and NeoplasmsHepatocellular CarcinomaMiddle Agedmedicine.diseaseAblationFibrosisdigestive system diseasessurgical procedures operativeTreatment OutcomeCirrhosisOncologyRadiological weaponHepatocellular carcinomaCatheter AblationMedicineHepatocellular carcinoma survival RFAlcsh:QFemalebusinessLiver cancerResearch ArticlePloS one
researchProduct

Eurotransplant special request for high-urgency status after liver transplantation for hepatocellular carcinoma: a case report.

2008

Hepatic artery thrombosis after liver transplantation remains a major indication for retransplantation. We report the case of a 49-year-old man with a hepatocellular carcinoma in the setting of cirrhosis associated with chronic hepatitis B and C infections who underwent split liver transplantation. The patient experienced a complicated postoperative course, characterized by 2 relaparotomies for necrosis of segment IV, and a late hepatic artery thrombosis, first discovered on postoperative day 20. His subsequent course was characterized by relapsing cholangitis and liver abscesses requiring antibiotics and percutaneous drainage. Transient control of the septic complications allowed for the f…

Malemedicine.medical_specialtyCirrhosisPercutaneousCarcinoma Hepatocellularmedicine.medical_treatmentLiver transplantationNecrosisHepatic ArterymedicineHumansTransplantationDeceased donorbusiness.industryLiver NeoplasmsCancerThrombosisMiddle Agedmedicine.diseaseHepatitis BHepatitis CSurgeryTumor recurrenceLiver TransplantationTreatment OutcomeHepatocellular carcinomaSurgeryEmergenciesLiver cancerbusinessTransplantation proceedings
researchProduct

Prostaglandin E2 receptors and COX enxymes in human hepatocellular carcinoma: role in the regulation of cell growth

2008

The aim of this study was to investigate the expression of prostaglandin E 2 receptors (EP 1-4 ), cyclooxygenase-1 (COX-1), and COX-2 in nontumor and tumor human liver tissues, and also to evaluate the antitumor activity of selective EP 1 receptor antagonist used alone or in combination with COX-1 and COX-2 selective inhibitors. Semiquantitative PCR analyses revealed that EP 1-4 , COX-1, and COX-2 mRNA expression was detected in nearly all the tissue samples assayed, although with a high variability between nontumor and tumor tissues. In vitro EP 1 receptor antagonist inhibited anchorage-independent cell growth and reduced the viability of hepatocellular carcinoma (HCC) cells in a dose-depe…

Malemedicine.medical_specialtyEP receptorSettore MED/09 - Medicina InternaCarcinoma Hepatocellularmedicine.drug_classProstaglandinmedicine.medical_treatmentGeneral Biochemistry Genetics and Molecular Biologyhepatocellular carcinoma (HCC)History and Philosophy of ScienceInternal medicineCell Line Tumormedicinecell growthHumansReceptors Prostaglandin EProstaglandin E2ReceptorAgedCOX-1ChemistryCell growthGeneral NeuroscienceLiver NeoplasmsCOX-2Middle Agedmedicine.diseaseReceptor antagonistNSAIDIn vitroCyclooxygenaseEndocrinologyProstaglandin-Endoperoxide SynthasesHepatocellular carcinomaSettore BIO/14 - FarmacologiaCancer researchFemaleLiver cancerCell DivisionProstaglandin Emedicine.drug
researchProduct

Minor hepatic resection using heat coagulative necrosis

2009

Intra- and postoperative bleeding represents an extremely serious and frequent complication of hepatic surgery. In this study, we evaluated the effectiveness of a radiofrequency (RF) device using heat to cause coagulative necrosis of the hepatic parenchyma to control hemostasis in minor hepatic resection. Between December 2005 and November 2007, a study was conducted of 21 patients undergoing 22 hepatic resections with the RF-assisted technique. Sixteen of these were affected by hepatocellular carcinoma and five had liver metastases from colorectal cancer. Intraoperative blood loss, the need for blood transfusion, the complication rates, operating times, and the duration of postoperative h…

Malemedicine.medical_specialtyNecrosisBlood transfusionCarcinoma HepatocellularColorectal cancermedicine.medical_treatmentBlood Loss SurgicalHemoglobinsmedicineliver metastases cancer surgeryHepatectomyHumansAgedbusiness.industryLiver NeoplasmsGeneral MedicineLength of StayMiddle Agedmedicine.diseaseHemostasis SurgicalSurgerySettore MED/18 - Chirurgia GeneraleCoagulative necrosisHematocritHemostasisAnesthesiaHepatocellular carcinomaCatheter AblationFemalemedicine.symptomHepatectomyComplicationbusiness
researchProduct

Minor hepatic resection for hepatocellular carcinoma in cirrhotic patients: Kelly clamp crushing resection versus heat coagulative necrosis with bipo…

2011

Hemorrhage and postoperative liver insufficiency are frequent and serious complications of hepatic resection in cirrhotic patients. The aim of this study was to assess retrospectively whether the surgical techniques using Kelly clamp crushing resection or heat coagulative necrosis with a bipolar radiofrequency device can reduce the incidence of the above complications and an eventual recurrence of neoplasia on the liver slice. We retrospectively reviewed the results of 35 patients who had undergone resection for monofocal hepatocellular carcinoma at our center. Thirteen patients (Group A) had undergone liver resection with Kelly clamp crushing resection, 22 patients (Group B) had had liver…

Malemedicine.medical_specialtyNecrosisCarcinoma HepatocellularTime Factorsmedicine.medical_treatmentBlood Loss SurgicalGastroenterologyNecrosisLaparotomyInternal medicinemedicineCarcinomaHepatectomyHumansHCC Liver Cirrhosis Resection Coagulative necrosis Bipolar radiofrequency deviceAgedRetrospective StudiesLaparotomybusiness.industryLiver NeoplasmsRetrospective cohort studyGeneral MedicineEquipment Designmedicine.diseaseSurgical InstrumentsHemostasis SurgicalSurgerySettore MED/18 - Chirurgia GeneraleClampCoagulative necrosisTreatment OutcomeLiverHemostasisHepatocellular carcinomaCatheter AblationFemalemedicine.symptombusinessFollow-Up Studies
researchProduct

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.

2014

Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to lead-time bias. Data regarding lead-time for HCC are lacking. Aims of the present study were to calculate lead-time and to assess its impact on the benefit obtainable from the surveillance of cirrhotic patients. Background & Aims: Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to …

Malemedicine.medical_specialtyPediatricsCarcinoma HepatocellularTime FactorsHepatocellular carcinomaSettore MED/12 - GASTROENTEROLOGIADiseaseGastroenterologyBiasInternal medicineOverall survivalmedicineHumansEarly Detection of CancerAgedEstimationSurveillanceHepatologybusiness.industryLiver Neoplasmsmedicine.diseasedigestive system diseasesLead time biasCirrhosisHepatocellular carcinomaFemalebusinessLead-time biasFollow-Up Studies
researchProduct

Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer

2017

The debate about the best approach to select patients with hepatocellular cancer (HCC) waiting for liver transplantation (LT) is still ongoing. This study aims to identify the best variables allowing to discriminate between "high-" and "low-benefit" patients. To do so, the concept of intention-to-treat (ITT) survival benefit of LT has been created. Data of 2,103 adult HCC patients consecutively enlisted during the period 1987-2015 were analyzed. Three rigorous statistical steps were used in order to create the ITT survival benefit of LT: the development of an ITT LT and a non-LT survival model, and the individual prediction of the ITT survival benefit of LT defined as the difference between…

Malemedicine.medical_specialtySettore MED/18 - CHIRURGIA GENERALEmedicine.medical_treatment030230 surgeryMilan criteriaLiver transplantation03 medical and health sciencesLiver disease0302 clinical medicineInternal medicinemedicineCarcinoma Hepatocellular; Europe; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Liver Transplantation; HepatologyHumansRisk factorHepatology; hepatocellular cancer; liver transplantationCarcinoma Hepatocellular; Europe; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Liver TransplantationSurvival analysisRetrospective StudiesIntention-to-treat analysisHepatologybusiness.industryCarcinomaLiver NeoplasmsRetrospective cohort studyHepatocellularHepatologyMiddle Agedmedicine.diseaseSurgeryLiver TransplantationSettore MED/18Europehepatocellular cancer030211 gastroenterology & hepatologyFemalebusiness
researchProduct